期刊文献+

B族链球菌C5a肽酶表位的预测、分段表达及其免疫原性 被引量:3

Epitope Prediction,Fractional Expression and Immunogenicity of Streptococcal C5a Peptidase from Group B Streptococcus
原文传递
导出
摘要 目的应用生物信息学方法预测B族链球菌C5a肽酶蛋白(SCPB)的表位,分段表达其中4个功能活性区域,并分析其免疫原性。方法用预测程序ProPred和ANTIGENIC预测SCPB的表位;分别构建C5a肽酶4个目的片段的重组表达质粒,经酶切测序正确后,转化E. coli BL21(DE3),IPTG诱导表达,SDS-PAGE分析目的蛋白的表达形式及表达量;并经镍柱亲和层析纯化,纯化的重组蛋白进行蛋白质谱分析和Western blot分析后,皮下免疫小鼠,ELISA检测小鼠血清抗体水平。结果经预测,SCPB含1个既可结合MHC又具有B细胞表位特征的肽段。构建的4个重组表达质粒经酶切及测序鉴定正确,目的蛋白主要以可溶性形式表达,表达量约占菌体总蛋白的30%~70%。纯化的重组蛋白纯度可达90%,质谱分析表明与SCPB的相似性很高;Western blot分析表明,可与兔抗全长SCPB多克隆抗体反应。重组F1、FE、Fn蛋白免疫小鼠血清抗体滴度较高,三者差异无统计学意义;F2a蛋白抗体滴度最低,与F1、FE和Fn蛋白差异有统计学意义。结论已成功构建并高效表达了SCPB的4个功能活性区域;Fn是重要的免疫优势表位功能区;本文为B族链球菌毒力机制的研究及亚单位蛋白疫苗的研制奠定了基础。 Objective To predict the epitopes,fractionally express the four functional domains and analyze the immunogenicity of streptococcal C5a peptidase from group B streptococcus(SCPB).Methods The epitopes of SCPB were predicted by using ProPred and ANTIGENIC softwares.The recombinant plasmids carrying the four target gene fragments of SCPB were constructed respectively,identified by restriction analysis and sequencing,then transformed to E.coli BL21(DE3)for expression under induction of IPTG.The target protein was analyzed for form and expression level by SDS-PAGE,and purified by nickel ion affinity chromatography,then analyzed by peptide mass fingerprinting(PMF)and Western blot.C57 /BL mice were immunized s.c.with the purified protein and determined for serum antibody.Results It was predicted that SCPB contained a peptide fragment which could bind to MHC and showed the characters of B cell epitope.Both restriction analysis and sequencing proved that the four recombinant plasmids were constructed correctly.The expressed products mainly existed in soluble forms and contained about 30%~70% of total somatic protein.The purified recombinant proteins reached purities of 90%,and showed high homologies to SCPB as proved by PMF.Western blot showed specific reaction of the purified recombinant protein with rabbit polyclonal antibody against full-length of SCPB.High antibody titers were induced in the sera of mice by recombinant F1,FE and Fn proteins,which showed no significant difference.However,the antibody titer induced by F2a protein was significantly lower than those by the above-mentioned three kinds of proteins.Conclusion The four functional domains of SCPB were successfully constructed and highly expressed,and Fn was an important functional domain of prominent immune epitope,which laid a foundation of study on virulence mechanism of group B streptococcus(GBS)and development of GBS subunit vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第5期460-465,共6页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30371487)
关键词 B族链球菌 C5a肽酶 表位 分段表达 免疫原性 Group B streptococcus(GBS) C5a peptidase Epitope Fractional expression Immunogenicity
  • 相关文献

参考文献12

  • 1Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev, 1994, 16 (2): 374-402.
  • 2Cheng Q, Debol S, Lam H, et al. Immunization with C5a peptidase or peptidase-type Ⅲ polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice. Infeet Immun, 2002, 70 (11): 6409-6415.
  • 3岳丽琴,沈叙庄,周育森,林粱,杨永弘.B族链球菌C5a肽酶功能活性区域的分段表达[J].中国生物制品学杂志,2006,19(2):116-119. 被引量:1
  • 4Gleich-Theurer U, Aymanns S, Haas G, et al. Human serum induces streptococcal c5a peptidase expression. Infect Immun, 2009, 77 (9): 3817-3825.
  • 5Santillan DA, Andracki ME, Hunter SK. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. Am J Obstet Gynecol, 2008, 198 ( 1 ): 114.e1-e6.
  • 6Vordermeier M, Whelan AO, Hewinson RG. Recognition of mycobacterial epitopes by T ceils across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Intect Immun, 2003, 71 (4): 1980-1987.
  • 7AL-Attiyah R, Mustafa AS. Computer-assisted prediction of HIADR binding and experimental analysis for human promiscuous Thl cell peptides in the 24 kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand J Immunol, 2004, 59 (1): 16-24.
  • 8Chmouryguina I, Suvorov A, Ferrieri P, et al. Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun, 1996, 64 (7): 2387-2390.
  • 9Cleary PP, Matsuka YV, Huynh T, et al. Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice. Vaccine, 2004, 22 (31-32): 4332-4341.
  • 10Stafslien DK, Cleary PP. Characterization of the streptococcal CSa peptidase using a C5a-green fluorescent protein fusion protein substrate. J Bacteriol, 2000, 182 ( 11 ): 3254-3258.

二级参考文献6

  • 1Schuchat A,Wenger JD.Epidemiology of group B streptococcal disease.Risk factors,prevention strategies,and vaccine development.Epidemiol Rev,1994,16:374-402.
  • 2Cheng Q,Debol S,Lam H,et al.Immunization with C5a peptidase or peptidase-type Ⅲ polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.Infect Immun,2002,70:6409-6415.
  • 3Ji Y,McLansborough L,Kondagunta A,et al.C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.Infect Immun,1996,64:503-510.
  • 4Cheng Q,Stafslien D,Purushothaman SS,et al.The group B streptococcal C5a peptidase is both a specific protease and a invasin.Infect Immun,2002,70:2408-2413.
  • 5Bohnsack JF,Widjaja K,Ghazizadeh S,et al.A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infection.J Infect Dis,1997,175:847-855.
  • 6Cheng Q,Carlson B,Pillai S,et al.Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.Infect Immun,2001,69:2302-2308.

同被引文献25

  • 1杨育芳,梁琳琳,孙雪南,董兆麟.B群链球菌的培养及优化研究[J].微生物学杂志,2006,26(3):31-34. 被引量:4
  • 2张继东,李淑芳,苑方重,付本懂,杨淑亚.奶牛乳房炎病原菌的分离鉴定和中药防治试验[J].中国兽医杂志,2006,42(11):32-33. 被引量:16
  • 3Forsman P,Tilsala-Timisjarvil A,Alatossava A.Identifica-tion of staphylococcal and streptococcal causes of bovine masti- tis using 16S-23SrRNA spacer regions[J].Microbiology,1997,143(11):3491-3500.
  • 4Riffon R,Sayasith K,Khalil H,et al.Development of a rapid andsensitive test for identification of major pathogens in bovine masti-tis by PCR[J].J Clin Microbiol,2001,39(7):2584-2589.
  • 5Lindahl G,Stalhammar-Carlemalm M,Areschoug T.Surfaceproteins of Streptococcus agalactiae and related proteins inother bacterial pathogens[J].Clin Microbiol Revi,2005,18(1):102-127.
  • 6Stalhammar-Carlemalm M,Stenberg L,Lindahl G.ProteinRib:a novel group B streptococcal cell surface protein thatconfers protective immunity and is expressed by most strainscausing invasive infections[J].J Exp Med,1993,177(6):1593-1603.
  • 7Areschoug T,Stalhammar-Carlemamm M,Larsson C,et al.Group B streptococcal surface proteins as targets for protectiveantibodies:identification of two novel proteins in strains of se-rotype V[J].Infect Immun,1999,67(12):6350-6357.
  • 8清华大学.大肠杆菌菌体多克隆抗体及其制备方法与应用:中国,200610113827.9[P].2007-03-28.
  • 9Larsson C,Stalhammar-Carlemalm M,Lindahl G.Protec-tion against experimental infection with group BStreptococcus by immunization with a bivalent protein vaccine[J].Vaccine,1999,17(5):454-458.
  • 10Gravekamp C,Kasper D L,Michel J L,et al.Immunogenic-ity and protective efficacy of the alpha C protein of group Bstreptococci are inversely related to the number of repeats[J].Infect.Immun,1997,65(12):5216-5221.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部